Follow
Jean-Claude Cutz
Jean-Claude Cutz
Pathology and Molecular Medicine, McMaster University
Verified email at mcmaster.ca
Title
Cited by
Cited by
Year
Erlotinib in lung cancer—molecular and clinical predictors of outcome
MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ...
New England Journal of Medicine 353 (2), 133-144, 2005
22942005
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
CQ Zhu, G da Cunha Santos, K Ding, A Sakurada, JC Cutz, N Liu, ...
Journal of clinical oncology 26 (26), 4268-4275, 2008
8622008
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
Y Storozhuk, SN Hopmans, T Sanli, C Barron, E Tsiani, JC Cutz, G Pond, ...
British journal of cancer 108 (10), 2021-2032, 2013
3182013
Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells
T Sanli, A Rashid, C Liu, S Harding, RG Bristow, JC Cutz, G Singh, ...
International Journal of Radiation Oncology* Biology* Physics 78 (1), 221-229, 2010
2522010
Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias
M Yoshimoto, JC Cutz, PAS Nuin, AM Joshua, J Bayani, AJ Evans, ...
Cancer genetics and cytogenetics 169 (2), 128-137, 2006
2152006
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
MC Tammemagi, H Schmidt, S Martel, A McWilliams, JR Goffin, ...
The lancet oncology 18 (11), 1523-1531, 2017
2012017
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148
AM Oza, EA Eisenhauer, L Elit, JC Cutz, A Sakurada, MS Tsao, ...
Journal of Clinical Oncology 26 (26), 4319-4325, 2008
1562008
Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells
AP Rybak, L He, A Kapoor, JC Cutz, D Tang
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (5), 683-694, 2011
1482011
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential …
JC Cutz, J Guan, J Bayani, M Yoshimoto, H Xue, M Sutcliffe, J English, ...
Clinical cancer research 12 (13), 4043-4054, 2006
1392006
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line
Y Wang, H Xue, JC Cutz, J Bayani, NR Mawji, WG Chen, LJ Goetz, ...
Laboratory investigation 85 (11), 1392-1404, 2005
1382005
Sulfasalazine‐induced cystine starvation: potential use for prostate cancer therapy
DW Doxsee, PW Gout, T Kurita, M Lo, AR Buckley, Y Wang, H Xue, ...
The Prostate 67 (2), 162-171, 2007
1342007
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer
CQ Zhu, JC Cutz, N Liu, D Lau, FA Shepherd, JA Squire, MS Tsao
British journal of cancer 94 (10), 1452-1459, 2006
1272006
Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer
S Djalalov, J Beca, JS Hoch, M Krahn, MS Tsao, JC Cutz, NB Leighl
J Clin Oncol 32 (10), 1012-1019, 2014
1052014
Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer
JC Cutz, KJ Craddock, E Torlakovic, G Brandao, RF Carter, G Bigras, ...
Journal of Thoracic Oncology 9 (9), 1255-1263, 2014
862014
α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells
L He, C Fan, A Kapoor, AJ Ingram, AP Rybak, RC Austin, J Dickhout, ...
Nature communications 2 (1), 307, 2011
832011
IQGAP2, A candidate tumour suppressor of prostate tumorigenesis
Y Xie, J Yan, JC Cutz, AP Rybak, L He, F Wei, A Kapoor, VA Schmidt, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (6), 875-884, 2012
732012
Bmi1 promotes prostate tumorigenesis via inhibiting p16INK4A and p14ARF expression
C Fan, L He, A Kapoor, A Gillis, AP Rybak, JC Cutz, D Tang
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1782 (11 …, 2008
722008
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis
J Yan, J De Melo, JC Cutz, T Aziz, D Tang
British journal of cancer 110 (10), 2593-2603, 2014
712014
PTEN inhibits BMI1 function independently of its phosphatase activity
C Fan, L He, A Kapoor, AP Rybak, J De Melo, JC Cutz, D Tang
Molecular cancer 8, 1-14, 2009
692009
Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for …
K Al-Romaih, GR Somers, J Bayani, S Hughes, M Prasad, JC Cutz, H Xue, ...
Cancer cell international 7, 1-16, 2007
642007
The system can't perform the operation now. Try again later.
Articles 1–20